Latest Commercial Milestones News

Maas Group Holdings has agreed to sell its Construction Materials division for up to $1.703 billion, marking a strategic pivot towards digital infrastructure and electrification sectors. The deal, expected to close in late 2026, includes a significant minority investment in AI infrastructure developer Firmus Grid.

OncoSil Medical secures $8 million in capital to fund a pivotal German government-sponsored clinical trial and accelerate its European commercial expansion.

Memphasys Limited secures significant repeat orders from Hamad Medical Corporation, marking a pivotal expansion of its Felix™ system across the MENA region.

Invictus Energy has reached a pivotal milestone by finalising the Petroleum Production Sharing Agreement for its Cabora Bassa Project, setting the stage for exploration and appraisal drilling in Zimbabwe in 2026. Meanwhile, the company has ended its strategic partnership with Al Mansour Holdings and is actively pursuing new funding avenues.

Clean TeQ Water Limited reported strong operational progress in Q2 FY26, highlighted by a $19 million contract with Rio Tinto and a successful $6 million capital raise. The company is advancing multiple water treatment and critical minerals projects globally.

Weebit Nano has landed its largest customer yet with Texas Instruments licensing its ReRAM technology, while achieving key technical milestones and doubling its revenue guidance for FY26.

Papyrus Australia has taken a significant step towards commercialisation with a $4.2 million supply contract and the near completion of its Adelaide Rapid Prototyping and R&D Facility.

OncoSil Medical has reported a record quarter for dose sales alongside key European market entries and a successful manufacturing milestone, signalling growing momentum for its pancreatic cancer treatment.

Sparc Technologies has marked a significant milestone with sustained hydrogen production at its pioneering pilot plant and secured key patents, while also achieving its first commercial sale of graphene additives.

Mach7 Technologies reports a positive operating cash flow in Q2 FY26, securing its first customer for the new Flamingo Architecture product and advancing key strategic initiatives.

Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.

Aurora Labs has marked a significant milestone by securing its first purchase order for micro gas turbine engines, alongside strategic MOUs with major defence groups and a $5.5 million capital raise to fuel growth.